very interesting -- thanks for sharing. I wondered though, if such an in-lab software releases under FOSS license could then it be re-used or better built-upon in another lab without violating FDA/etc regulations?
In-house developments resting on the work of FOSS projects are nice but is there a way those could contribute back to the ecosystem? What if such are exposed as 'services' and not 'software/devices' -- could then they be re-used within current legal framework(s)? On Tue, 20 May 2014, Andreas Tille wrote: > Hi, > I think this paper might also be of interest for readers of Debian Med > list ... > Kind regards > Andreas. > ----- Forwarded message from Ian Malone <[email protected]> ----- > Date: Tue, 20 May 2014 12:22:21 +0100 > From: Ian Malone <[email protected]> > To: FedoraMedical <[email protected]> > Subject: paper: Custom software development for use in a clinical laboratory > Hi, been a bit quiet here of late. > Anyway, was reading this this morning and thought it might be of > interest to some: > J Pathol Inform. 2012; 3: 44. > Published online Dec 20, 2012. doi: 10.4103/2153-3539.104906 > PMCID: PMC3551490 > Custom software development for use in a clinical laboratory > John H. Sinard* and Peter Gershkovich > http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551490/ > (Open Access) -- Yaroslav O. Halchenko, Ph.D. http://neuro.debian.net http://www.pymvpa.org http://www.fail2ban.org Research Scientist, Psychological and Brain Sciences Dept. Dartmouth College, 419 Moore Hall, Hinman Box 6207, Hanover, NH 03755 Phone: +1 (603) 646-9834 Fax: +1 (603) 646-1419 WWW: http://www.linkedin.com/in/yarik -- To UNSUBSCRIBE, email to [email protected] with a subject of "unsubscribe". Trouble? Contact [email protected] Archive: https://lists.debian.org/[email protected]
